U.S. Markets closed

Allergan plc (AGN)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
223.12-1.24 (-0.55%)
At close: 4:02PM EDT
People also watch
BIIBCELGVRXGILDREGN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue14,570,60012,688,1004,676,500
Cost of Revenue1,860,8002,751,8001,704,800
Gross Profit12,709,8009,936,3002,971,700
Operating Expenses
Research Development2,575,7002,358,500605,700
Selling General and Administrative4,740,3004,481,5002,267,400
Non Recurring748,900783,600730,000
Others6,470,4005,443,7001,935,800
Total Operating Expenses14,535,30013,067,3005,538,900
Operating Income or Loss-1,825,500-3,131,000-2,567,200
Income from Continuing Operations
Total Other Income/Expenses Net289,100-223,200-19,200
Earnings Before Interest and Taxes-1,536,400-3,354,200-2,586,400
Interest Expense1,295,6001,193,300411,800
Income Before Tax-2,832,000-4,547,500-2,998,200
Income Tax Expense-1,897,000-1,605,900-513,600
Minority Interest7,800-2,1004,400
Net Income From Continuing Ops-935,000-2,941,600-2,484,600
Non-recurring Events
Discontinued Operations15,914,5006,861,000854,100
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income14,973,4003,915,200-1,630,500
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares14,695,0003,683,200-1,630,500